Jay A. Berzofsky

Active 1971–2025

186
Papers
31,573
Citations
105
h-index
184
i10-index

Citations

Citations per year for Jay A. Berzofsky1969: 2 citations1970: 1 citations1971: 1 citations1973: 1 citations1975: 1 citations1976: 1 citations1977: 2 citations1978: 3 citations1979: 4 citations1980: 5 citations1981: 5 citations1982: 11 citations1983: 10 citations1984: 22 citations1985: 29 citations1986: 70 citations1987: 101 citations1988: 152 citations1989: 165 citations1990: 101 citations1991: 145 citations1992: 123 citations1993: 149 citations1994: 192 citations1995: 192 citations1996: 142 citations1997: 180 citations1998: 242 citations1999: 235 citations2000: 180 citations2001: 236 citations2002: 218 citations2003: 179 citations2004: 281 citations2005: 272 citations2006: 250 citations2007: 270 citations2008: 261 citations2009: 283 citations2010: 279 citations2011: 217 citations2012: 184 citations2013: 174 citations2014: 155 citations2015: 157 citations2016: 131 citations2017: 142 citations2018: 162 citations2019: 463 citations2020: 558 citations2021: 627 citations2022: 522 citations2023: 431 citations2024: 530 citations2025: 300 citations2026: 12 citations1972: no citations, so this year is not shown1974: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,884 citing papers, 36% of this breakdownChina: 1,100 citing papers, 10.2% of this breakdownUnited Kingdom: 621 citing papers, 5.8% of this breakdownGermany: 493 citing papers, 4.6% of this breakdownFrance: 466 citing papers, 4.3% of this breakdownItaly: 391 citing papers, 3.6% of this breakdownAustralia: 359 citing papers, 3.3% of this breakdownJapan: 334 citing papers, 3.1% of this breakdownCanada: 325 citing papers, 3% of this breakdownNetherlands: 227 citing papers, 2.1% of this breakdownSwitzerland: 210 citing papers, 2% of this breakdownIndia: 174 citing papers, 1.6% of this breakdown
0%36%Other 20.4%

Fields

  • Immunology and Microbiology39.1%
  • Medicine31.9%
  • Biochemistry, Genetics and Molecular Biology25.1%
  • Agricultural and Biological Sciences0.8%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Neuroscience0.5%
  • Other2%

Topics

  • Immunotherapy and Immune Responses8.4%
  • Immune Cell Function and Interaction8.3%
  • T-cell and B-cell Immunology5.3%
  • Cancer Immunotherapy and Biomarkers3.7%
  • Gut microbiota and health2.7%
  • CAR-T cell therapy research2.4%
  • Other69.2%

Coauthors

All papers

Open in search
  1. Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Science 2018 cited by 1,511

  2. Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma

    Authors: , , , , , , , , - PLoS ONE 2014 cited by 483

  3. Labeling Extracellular Vesicles for Nanoscale Flow Cytometry

    Authors: , , , , , , , , , , , , , , , , - Scientific Reports 2017 cited by 377

  4. Mutant KRAS Conversion of Conventional T Cells into Regulatory T Cells

    Authors: , , , , , , , , , , , - Cancer Immunology Research 2016 cited by 161

  5. Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2022 cited by 110

  6. IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells

    Authors: , , , , , , , , , , - The Journal of Experimental Medicine 2013 cited by 245

  7. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function

    Authors: , , , , , , , , , , , - The Journal of Experimental Medicine 2005 cited by 711

  8. Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008)

    Authors: , , , , , , , , , - Cancer Immunology Immunotherapy 2015 cited by 150

  9. High‐fidelity detection and sorting of nanoscale vesicles in viral disease and cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter L. Choyke, Susan J. Knox, Ionita Ghiran, Marjorie Robert‐Guroff, Jay A. Berzofsky, Jennifer Jones - Journal of Extracellular Vesicles 2019 cited by 130

  10. Unique challenges for glioblastoma immunotherapy—discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William C. Timmer, Patrick Y. Wen, Robert M. Prins, Michael Platten, Hideho Okada - Neuro-Oncology 2020 cited by 93

  11. Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy

    Authors: , , , , , , , , - OncoImmunology 2017 cited by 93

  12. Commensal DNA Limits Regulatory T Cell Conversion and Is a Natural Adjuvant of Intestinal Immune Responses

    Authors: , , , , , , , , - Immunity 2008 cited by 484

  13. Chapter 8 The Role of NKT Cells in Tumor Immunity

    Authors: , - Advances in cancer research 2008 cited by 308

  14. Selective Inhibition of Regulatory T Cells by Targeting the PI3K–Akt Pathway

    Authors: , , , , , , , - Cancer Immunology Research 2014 cited by 149

  15. NKT Cell Networks in the Regulation of Tumor Immunity

    Authors: , , - Frontiers in Immunology 2014 cited by 125

  16. Hydrophobicity scales and computational techniques for detecting amphipathic structures in proteins

    Authors: , , , , , - Journal of Molecular Biology 1987 cited by 644

  17. Tissue-Specific Roles of NKT Cells in Tumor Immunity

    Authors: , - Frontiers in Immunology 2018 cited by 142

  18. Transforming Growth Factor-β Production and Myeloid Cells Are an Effector Mechanism through Which CD1d-restricted T Cells Block Cytotoxic T Lymphocyte–mediated Tumor Immunosurveillance

    Authors: , , , , , , , , , , , , - The Journal of Experimental Medicine 2003 cited by 536

  19. SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage

    Authors: , , , - Frontiers in Immunology 2021 cited by 50

  20. Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 cited by 284

  21. An Anti–Transforming Growth Factor β Antibody Suppresses Metastasis via Cooperative Effects on Multiple Cell Compartments

    Authors: , , , , , , , , , , , , , , - Cancer Research 2008 cited by 227

  22. A Pilot Study of Consolidative Immunotherapy in Patients with High-Risk Pediatric Sarcomas

    Authors: , , , , , , , , , , , , , - Clinical Cancer Research 2008 cited by 158

  23. MPAPASS software enables stitched multiplex, multidimensional EV repertoire analysis and a standard framework for reporting bead-based assays

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eytan Ruppin, Kenneth Aldape, Kevin Camphausen, James L. Gulley, Ionita Ghiran, Steve Jacobson, Jennifer Jones - Cell Reports Methods 2022 cited by 27

  24. CD47 in the Tumor Microenvironment Limits Cooperation between Antitumor T-cell Immunity and Radiotherapy

    Authors: , , , , , , , - Cancer Research 2014 cited by 193